Other gut-derived targets for pharmacotherapy Although GIP and GLP-1 have been identified as the most important humoral mediators of the incretin effect, other gut-derived factors are also involved in glucose and energy homoeostasis and may therefore qualify as future therapeutic targets [13] (Fig
Systemic Effectiveness : Interestingly, BPC 157 can be injected systemically (e.g., in the abdomen) rather than directly at the injury site, and still provide benefits throughout the body
He had a keen interest as was recently needing B12 injections himself and not coping on the NHS regime
If you have digestive issues, inflammation, or anemia, you may struggle to get enough vitamin B12 from your diet alone
5 The recent rise in the demand for GLP-1RAs has led to unexpected drug shortages that have prevented patients who typically use these medications for glycemic management, weight loss, and/or cardiovascular risk reduction from experiencing new challenges in their access to GLP-1RAs
Diabetes 120 , 132138 (2012)
